On January 25, 2024, the day following the proposed PDUFA goal date, Liquidia Corporation announced the FDA was still reviewing the NDA for pulmonary hypertension with interstitial lung disease for treprostinil inhalation powder (Yutrepia).
Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2022 Earnings Conference Call May 4, 2022, 04:30 PM ET Company Participants Diane Weiser - SVP of Corporate Communications and IR Robert.
Influenza Vaccine Trials Could Give Insights into Testing COVID-19 Interventions pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.